Viewing StudyNCT00590785



Ignite Creation Date: 2024-05-05 @ 7:03 PM
Last Modification Date: 2024-10-26 @ 9:40 AM
Study NCT ID: NCT00590785
Status: COMPLETED
Last Update Posted: 2017-08-25
First Post: 2007-12-26

Brief Title: Phase III Comparison of Adjuvant Chemotherapy WHigh-Dose Cyclophosphamide Plus Doxorubicin AC vs Sequential Doxorubicin Fol by Cyclophosphamide A-C in High Risk Breast Cancer Patients With 0-3 Positive Nodes Intergroup CALGB 9394
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Doxorubicin
High Risk
Breast Cancer
Positive Nodes
Cyclophosphamide
Keywords:
Name View
96-041 View
High Risk View
Breast Cancer View
Positive Nodes View
Cyclophosphamide View
Doxorubicin View